Akums Drugs & Pharmaceuticals Ltd. IPO

Akums Drugs and Pharmaceuticals Limited is a leading CDMO in India, offering a wide range of pharmaceutical products and services. They are the largest domestic CDMO by revenue and have a strong track record of manufacturing complex formulations. With 10 manufacturing units and global accreditations, they serve 26 of India's top 30 pharma companies. Akums is expanding its capacity with a new injectable facility and is poised for further growth in the domestic and global CDMO markets.

RHP
View
DRHP
View
Open Date

2024-07-30

Close Date

2024-08-01

Akums Drugs & Pharmaceuticals Ltd. IPO Details

Check out the issue details for Akums Drugs & Pharmaceuticals Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 679

Price Band

₹ 646 - 679

Issue Size

1856.74 Cr.

Issue Type

Book Built

Open

2024-07-30

Close

2024-08-01

Listingprice

₹ 725

ListingGain

6.77%

Listing Date

2024-08-06

CMP

₹ 609.65

Current Return

-10.21%

Akums Drugs & Pharmaceuticals Ltd. News

Akums Drugs enters into exclusive Master Sales Agreement with Caregen 19 Nov, 2:51PM Akums Drugs and Pharmaceuticals informs about press release11 Nov, 2:38PM Akums Drugs & Pharmaceuticals - Quaterly Results9 Nov, 5:51PM Akums Drugs & Pharmaceuticals - Quaterly Results9 Nov, 5:51PM Akums Drugs & Pharmaceuticals - Quaterly Results9 Nov, 5:51PM Akums Drugs and Pharmaceuticals enters into MoU with Government of Republic of Zambia18 Oct, 2:27PM Akums Drugs & Pharmaceuticals enters into license & distribution agreement with Triple Hair Inc16 Oct, 3:45PM Akums Drugs launches new product Famotidine, Calcium Carbonate and Magnesium Hydroxide10 Oct, 9:22AM Akums Drugs and Pharmaceuticals informs about closure of trading window30 Sep, 12:33PM Akums Drugs gets patent certificate from Government of India13 Sep, 10:46AM Akums Drugs and Pharmaceuticals informs about newspaper publication 26 Aug, 12:41PM Akums Drugs & Pharmaceuticals - Quaterly Results24 Aug, 5:30PM Akums Drugs and Pharmaceuticals informs about earnings call23 Aug, 2:49PM Akums Drugs’ arm starts second production facility at Haridwar manufacturing unit23 Aug, 11:00AM Akums Drugs and Pharmaceuticals coming with IPO to raise upto Rs 1893.21 crore27 Jul, 12:58PM Akums Drugs and Pharmaceuticals gets SEBI’s nod for IPO9 Jul, 2:40PM Akums Drugs and Pharmaceuticals files DRHP with SEBI14 Feb, 12:38PM

Company Financials

You can get the following financial statements of Akums Drugs & Pharmaceuticals Ltd. as of now.

Exchange

NSE: AKUMS BSE: 544222

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

The details about the Akums Drugs and Pharmaceuticals Limited IPO is as:

  • The issue size of the IPO is 1856.74 Cr.
  • The price band for Akums Drugs and Pharmaceuticals Limited IPO is Rs 646 to Rs 679.
  • The shares of Akums Drugs and Pharmaceuticals Limited IPO will list on 6th August 2024.
  • The latest tentative GMP of Akums Drugs and Pharmaceuticals Limited IPO is Rs 170.
  • The shares of Akums Drugs and Pharmaceuticals Limited IPO is subscribed 63.44 Times as of 1st August 2024. 

 

Akums Drugs and Pharmaceuticals Limited IPO Valuation

The approx valuation of Akums Drugs and Pharmaceuticals Limited IPO based on its price band and DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 679
Existing Shares (Qty) 14.73 Cr
Fresh Issue 680 Cr
Market Cap 10681.67 Cr
EPS (FY23) Rs -0.28
Industry PE 49.14x

 

Akums Drugs and Pharmaceuticals Limited IPO Issue Size

Akums Drugs and Pharmaceuticals Limited IPO issue size is 1856.74 Cr. 

Issue Amount
Fresh Issue 680 Cr
Offer For Sale 1262.83 Cr

 

Akums Drugs and Pharmaceuticals Limited IPO Market Lot

An Individual can apply for a minimum 1 lot of 22 shares and a maximum of 13 lots of 286 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 22 Rs 14,938
 Maximum 13 286 Rs 1,94,194

 

Akums Drugs and Pharmaceuticals Limited IPO share offer

The shares of Akums Drugs and Pharmaceuticals Limited IPO is subscribed 63.44 Times as of 1st August 2024. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Minimum 75% 90.09 Times
Non-Institutional Maximum 15% 42.10 Times
Retail Individual Maximum 10% 20.80 Times
Employee 2,43,902 Shares 4.14 Times
Total   63.44 Times

Find below the dates for Akums Drugs and Pharmaceuticals Limited IPO:

Schedule Date
Basis of Allotment 2 August 2024
Refunds 5 August 2024
Credit to Demat Account 5 August 2024
IPO Listing Date 6 August 2024

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 683.08 736.91 837.44 1162.06 1286.83
Total Expenditure 601.16 696.98 810.73 1524.1 1050.88
Operating Profit 81.92 39.92 26.7 -362.04 235.95
Other Income 56.87 65.52 54.51 58.48 102.08
Interest 3.88 4.34 0.82 3.65 13.18
Depreciation 22.86 25.26 26.1 27.76 30
Exceptional Items 0 0 -249.5 0 -144.53
Profit Before Tax 112.05 75.85 -195.2 -334.98 150.32
Provision for Tax 37.21 24.99 -49.77 46.8 24.89
Net Profit 74.84 50.86 -145.43 -381.78 125.43
Adjusted EPS (Rs.) 0.58 0.36 -1.02 -2.67 0.88

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 1.18 1.3 1.3 14.31 28.61
Total Reserves 840.65 711.02 565.75 171.23 282.89
Borrowings 0 0 0 0 21.88
Other N/C liabilities 48.93 535.99 551.55 1092.56 1061.14
Current liabilities 155.54 177.95 146 535.86 496.56
Total Liabilities 1046.29 1426.26 1264.6 1813.95 1891.07
Assets
Net Block 220.16 225.84 229.09 233.5 253.15
Capital WIP 0 1.13 1.26 0.52 16.13
Intangible WIP 0 0 0 0 0.12
Investments 20.23 81.18 130.45 141.39 139.16
Loans & Advances 503.86 587.56 508.57 858.15 937.52
Other N/C Assets 0.32 36.41 24.63 25.24 23.92
Current Assets 301.73 494.14 370.6 555.16 521.08
Total Assets 1046.29 1426.26 1264.6 1813.95 1891.07
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024
Other Income 26.18 32.12
Profit Before Tax 54.27 61.62
Tax 12.4 11.25
Profit After Tax 41.88 50.37
Adjusted EPS (Rs) 2.93 3.29

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 75.26 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 112.05 75.85 -195.2 -334.98 150.32
Adjustment -25.39 -26.46 -19.27 -11.93 -18.57
Changes in Assets & Liabilities -49.17 -22.68 -28.45 99.58 -81.51
Tax Paid -33.4 -46.32 -4.9 -7.19 -30.3
Operating Cash Flow 2.81 -21.75 55.57 228.31 94.01
Investing Cash Flow -14.78 -241.71 -99.96 -297.96 -202.17
Financing Cash Flow 15.35 301.53 2.6 94.99 89.9
Net Cash Flow 3.37 38.07 -41.79 25.34 -18.26
X